Novartis AG ADS (NVS) Share Price ($):70.55 Price Change: -0.48 (-0.68%)

Expand Company Information
Volume 1,596,174 Avg Volume 1,668,681
Day's Low $69.72 Day's High $70.56
52-wk Low $51.20 52-wk High $71.99
Previous Close $71.03 Open Price $69.86
Dividend $ 2.43 Yield 3.44%
Market Cap 189,954,000,000 P/E (Forward) 13.66
Chart for NVS
Exchange: NYSE Industry: Pharmaceuticals & Biotechnology Last Trade: 4:02 PM ET 4/5/2013
Last 10 Quotes: What's This?
    Find a Broker »
    Article Time Date Source
    The Case for Target and a Few Undertakers 11:25 AM Apr 5, 2013  Barrons.com
    Merck Unit, Sun Pharma File Patent Suit Against Glenmark 11:55 AM Apr 3, 2013 Dow Jones Global News Select
    Morning Research on Teva Pharma, Orexigen Therapeutics, Zoetis, and Novartis 8:01 AM Apr 3, 2013  PR
    The Multinational's Emerging Market Conundrum 11:30 AM Apr 2, 2013  Barrons.com
    MARKET SNAPSHOT: U.S. Stocks Retreat After Manufacturing Data 11:00 AM Apr 1, 2013 Dow Jones Global News Select
    MARKET SNAPSHOT: Stocks Steady Before Manufacturing Data 10:55 AM Apr 1, 2013 Dow Jones Global News Select
    MARKET SNAPSHOT: Stocks Mostly Down After Manufacturing Data 10:52 AM Apr 1, 2013 Dow Jones Global News Select
    Novartis: Won't Stop Selling New Drugs in India 6:36 AM Apr 1, 2013 Dow Jones Global News Select
    India Court Rejects Novartis Plea on Cancer Drug Patent 6:15 AM Apr 1, 2013 Dow Jones Global News Select
    India Supreme Court Rejects Novartis Plea on Cancer Drug Patent 1:54 AM Apr 1, 2013 Dow Jones Global News Select
    UPDATE: Biogen Prices Multiple-Sclerosis Drug Below Rivals 3:12 PM Mar 29, 2013 Dow Jones Global News Select
    Biogen Idec Prices Multiple-Sclerosis Drug 1:14 PM Mar 29, 2013 Dow Jones Global News Select
    Biogen Idec Prices Multiple-Sclerosis Drug Below Oral Competitor 12:18 PM Mar 29, 2013 Dow Jones Global News Select
    2ND UPDATE: FDA Approves Biogen's Pill to Treat Multiple Sclerosis 7:01 PM Mar 27, 2013 Dow Jones Global News Select
    Correction to Stories About FDA's Approval of Biogen's MS Pill 6:45 PM Mar 27, 2013 Dow Jones Global News Select
    UPDATE: FDA Approves Biogen's Pill to Treat Multiple Sclerosis 5:51 PM Mar 27, 2013 Dow Jones Global News Select
    Clinigen Buys Oncology Support Therapy Cardioxane from Novartis for $33 Million 4:34 AM Mar 26, 2013 Dow Jones Global News Select
    Healthy Upside for Drug Stocks 4:47 AM Mar 23, 2013  Barrons.com
    Enanta Pharmaceuticals Rises in IPO 11:14 AM Mar 21, 2013 Dow Jones Global News Select
    Enanta Pharmaceuticals Rises in IPO 10:54 AM Mar 21, 2013 Dow Jones Global News Select
    • Print Snapshot
    • Stock Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports
    tools

    Stock Screener

    Portfolio Tracker

    See More Tools